Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Sep 23, 2026
Quantum Computing Inc. (QUBT): Could the Stock Climb +120% to $20?

Quantum Computing Inc. (QUBT): Could the Stock Climb +120% to $20?

Key Takeaways

  • Quantum Computing Inc. (QUBT) trades near $9, meaning a move to the $20 stock price target would require roughly a 120% gain.
  • The strongest bullish case rests on explosive revenue growth, a growing contract backlog, and a large cash position.
  • The biggest obstacles are persistent net losses, high operating expenses, and heavy stock-price volatility in an unproven market.
  • Analyst price targets average around $18.67, with several firms publishing objectives between $20 and $22.
  • The $20 level is a major psychological and supply zone, sitting well below the 52-week high of $25.84.
  • Reaching $20 appears possible but not guaranteed; it would likely require sustained commercialization progress and renewed momentum across the quantum sector.

Why the $20 Level Matters

The central question many traders are asking is whether QUBT can climb back toward $20. That round number carries both psychological weight and practical significance: it sits just above the consensus analyst price target and was crossed during the stock's late-2025 surge before the shares retreated sharply. For a stock now changing hands near $9, reclaiming $20 would represent a decisive break out of its recent downtrend and a roughly 120% advance from current levels.

Company Snapshot

Quantum Computing Inc. is a quantum and integrated photonics company that develops quantum and quantum-inspired computing systems, photonic chips, and related services for government, education, and commercial customers. It competes in a young, rapidly evolving field alongside names like IonQ, D-Wave Quantum, and Rigetti Computing. The company has diversified beyond a single hardware approach through acquisitions, including NHanced Semiconductors, which expanded its advanced packaging and photonic integration capabilities. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

Current Market Position

QUBT carries a market capitalization of roughly $2 billion and a 52-week range between $6.18 and $25.84. The shares remain well below their peak and have been highly volatile, reflecting the speculative nature of the quantum-computing sector. Despite the price weakness, the company's financial position is notable: it reported approximately $1.3 billion in cash, cash equivalents, and investments at the end of its latest quarter, with total assets around $1.64 billion and stockholders' equity near $1.6 billion.

Analyst Price Targets

Wall Street's view provides useful context for the $20 question. The consensus analyst price target for QUBT sits near $18.67, with the average recommendation at "Buy." Individual targets range from a low of $10 to a high of $32, and several firms maintain objectives in the $20 to $22 range. This means the $20 level is not an outlier in the analyst community, but rather a figure consistent with the more constructive end of current coverage. Even so, the wide spread between the low and high targets underscores how uncertain the company's trajectory remains.

What Could Drive the Next Leg Higher

The most compelling argument for QUBT reaching $20 is the company's revenue trajectory. Second-quarter revenue jumped to roughly $5.6 million from just $61,000 a year earlier, while contract backlog reached approximately $42.5 million. If the company can convert its growing backlog into recognized revenue and expand deployments of systems such as its Dirac-3 quantum optimization machine, the fundamental story would strengthen meaningfully. The sizable cash balance also removes near-term dilution risk and gives management runway to scale manufacturing and commercialization. From what I see, this backlog conversion will be key to watch.

What Could Prevent the Move

Profitability remains the central challenge. The company posted a net loss of about $11.8 million in its latest quarter, with operating expenses of roughly $21.8 million outpacing revenue by a wide margin. Until revenue scales enough to absorb the expanded cost structure, QUBT will continue to depend on its cash reserves and on investor confidence in a technology that has yet to prove itself at commercial scale. A broader pullback in high-multiple, speculative growth names could also weigh on the shares regardless of company-specific progress.

Technical Levels That Matter

From a technical analysis perspective, $20 functions as both a psychological price level and a supply zone, given the stock's prior decline from its 52-week high. Before $20 can be tested, the shares would need to reclaim intermediate resistance in the low-to-mid teens, a region where the stock has previously struggled. On the downside, the $6.18 52-week low and the area near $8 represent important support levels that would need to hold for the bullish case to remain intact. A sustained trend reversal would require the stock to establish a series of higher lows, a pattern that has not yet been confirmed. I’m watching this closely with help from Tickeron’s AI Real Time Patterns for any early signals.

Market Sentiment and Sector Trends

Quantum-computing stocks tend to move as a group, reacting to breakthroughs, partnerships, and government funding announcements across the industry. Positive catalysts from peers have historically lifted the entire sector, including QUBT, while periods of risk aversion have punished these names disproportionately. Because QUBT has a high beta, its price swings are amplified relative to the broader market, which cuts both ways for anyone targeting the $20 level.

Using AI Signals for Monitoring

One tool I find helpful for monitoring names like this is Tickeron’s AI Daily Buy/Sell Signals. This resource applies artificial intelligence to scan thousands of stocks and ETFs in real time, delivering Buy, Sell, or Hold signals drawn from technical patterns and market behavior. It has become a practical part of my routine for spotting potential shifts in volatile names without relying solely on manual review.

Final Assessment

A move to $20 for QUBT is plausible but far from assured. The case in favor rests on accelerating revenue, a substantial backlog, a strong balance sheet, and analyst targets that sit in a similar range. The case against centers on continued losses, a cost structure that still outpaces sales, and the inherent unpredictability of an emerging technology. Investors should monitor revenue growth, backlog conversion, progress toward profitability, and the overall momentum of the quantum-computing sector. Those factors, more than any single price level, will determine whether the $20 stock price target is ultimately reachable.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: QUBT

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


QUBT's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for QUBT turned positive on September 17, 2026. Looking at past instances where QUBT's MACD turned positive, the stock continued to rise in 41 of 45 cases over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 16, 2026. You may want to consider a long position or call options on QUBT as a result. In 66 of 81 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 81%.

QUBT moved above its 50-day moving average on September 17, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +4.37% 3-day Advance, the price is estimated to grow further. Considering data from situations where QUBT advanced for three days, in 192 of 225 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.

Bearish Trend Analysis

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where QUBT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.

QUBT broke above its upper Bollinger Band on September 17, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for QUBT entered a downward trend on September 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 61 (best 1 - 100 worst), indicating fairly steady price growth. QUBT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.274) is normal, around the industry mean (7.364). P/E Ratio (0.000) is within average values for comparable stocks, (49.824). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (23.980). Dividend Yield (0.000) settles around the average of (0.004) among similar stocks. P/S Ratio (169.492) is also within normal values, averaging (51.774).

The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 92 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. QUBT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock worse than average.

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

Notable companies

The most notable companies in this group are Dell Technologies (NYSE:DELL), Arista Networks Inc (NYSE:ANET), Seagate Technology Holdings PLC (NASDAQ:STX), Western Digital Corp (NASDAQ:WDC), HP (NYSE:HPQ), 3D Systems Corp (NYSE:DDD).

Industry description

Computer Processing Hardware industry produces central processing unit, monitor, keyboard, computer data storage devices, and graphics card. Business activity and economic growth are potential drivers of this industry – if more businesses are growing or flourishing, so would their investments in computer equipment. Dell Technologies, Inc, Hewlett Packard Enterprise Co., NCR Corporation are key producers of computer processing hardware.

Market Cap

The average market capitalization across the Computer Processing Hardware Industry is 32.09B. The market cap for tickers in the group ranges from -0.18 to 365.79B. DELL holds the highest valuation in this group at 365.79B. The lowest valued company is HAUP at -0.18.

High and low price notable news

The average weekly price growth across all stocks in the Computer Processing Hardware Industry was 6%. For the same Industry, the average monthly price growth was -2%, and the average quarterly price growth was 47%. QCLS experienced the highest price growth at 102%, while XTND experienced the biggest fall at -11%.

Volume

The average weekly volume growth across all stocks in the Computer Processing Hardware Industry was 19%. For the same stocks of the Industry, the average monthly volume growth was -36% and the average quarterly volume growth was -49%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 67
Price Growth Rating: 55
SMR Rating: 79
Profit Risk Rating: 85
Seasonality Score: 13 (-100 ... +100)
View a ticker or compare two or three
QUBT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry ComputerProcessingHardware

Industry
N/A
Address
No.5 Marine View Plaza
Phone
+1 703 436-2121
Employees
77
Web
https://www.quantumcomputinginc.com
Interact to see
Advertisement
USAS fell over 10% today, trading around US$5.83 by early afternoon from a previous close of US$6.55 — a one‑day decline of roughly 11% — as more than 5.9 million shares changed hands. The stock had surged earlier in 2026, with some data showing a move from about US$1.11 in March 2025 to over US$7.30 in mid‑March 2026 — a gain of more than 500% — leaving it vulnerable to profit‑taking.
CENX fell about 8.9% today, dropping US$4.94 to US$50.40 by midday, after closing at US$55.34 yesterday; shares now sit roughly 15% below their 52‑week high of US$59.12 but remain far above the 12‑month low of US$13.05. Q4 2025 results showed net sales of US$633.7 million and adjusted net income of US$128.2 million (US$1.25 per share), with adjusted EBITDA of US$170.6 million — a big sequential improvement — but GAAP net income was just US$1.8 million (US$0.02 per share), underscoring earnings volatility.
CNL shares fell over 8% today, trading down from around C$22.90 toward the low‑C$21s, after recently setting a new 1‑year high at C$28.99 on March 2 and gaining more than 70% over the past 12 months.
SMCI shares are plunging approximately 26% in Friday premarket trading, extending sharp after-hours losses from Thursday's session close of $30.79. The primary catalyst is a federal indictment unsealed March 19, 2026, charging three individuals associated with Super Micro — including a company co-founder — with conspiring to illegally export billions of dollars in AI server technology to China.
PL shares are surging approximately 19% in premarket trading on March 20, 2026, building on an 8.67% gain during the regular session on March 19. The primary catalyst is a blowout Q4 fiscal year 2026 earnings report released after the close on March 19, with quarterly revenue of $86.8 million — an 11.55% beat against consensus expectations of $77.81 million.
Unusual Machines (UMAC) is trading down approximately -8.60% in premarket on March 20, 2026, extending losses from the prior session. The primary catalyst is a proposed public stock offering announced after the market close on March 19, 2026, raising dilution concerns among investors.
FDX surged approximately 7% in premarket trading on March 20, 2026, moving from the prior session close of $356.11 to around $381. The primary catalyst is a blowout fiscal Q3 2026 earnings report, with adjusted EPS of $5.25 — beating Wall Street's consensus estimate of $4.13 by more than 27%.
Kingsoft Cloud Holdings Limited (KC) shares plunged about 9% in the most recent session, extending a sharp pullback after a recent rally. The selloff reflects mounting concerns around profitability, with the company still loss-making and showing weak multi-year revenue growth.
BAK shares fell roughly 11% in the latest trading session, marking a sharp single-day drop for the Brazilian petrochemical producer The decline comes amid persistent concerns about high leverage, a weaker credit profile, and soft petrochemical margins in a challenging macro environment for chemicals​
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.
SEDG is indicated down roughly 9% in premarket trading, following a strong advance in the prior regular session. The pullback comes after shares rallied on optimism around new product launches and an analyst upgrade, leaving the stock vulnerable to profit-taking and volatility.
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.